Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 4441 AL 4455

EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force

EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:; Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M.

Eur J Neurol. 2012 Mar;19(3):360-75. doi: 10.1111/j.1468-1331.2011.03501.x. Epub 2011 Sep 14.

De novo interstitial triplication of MECP2 in a girl with neurodevelopmental disorder and random X chromosome inactivation

Mayo S, Monfort S, Roselló M, Orellana C, Oltra S, Armstrong J, Català V, Martínez F.

Cytogenet Genome Res. 2011;135(2):93-101. doi: 10.1159/000330917. Epub 2011 Sep 16.

Obturator nerve block with botulinum toxin type B for patient with adductor thigh muscle spasm -a case report-

Choi EJ, Byun JM, Nahm FS, Lee PB.

Korean J Pain. 2011 Sep;24(3):164-8. doi: 10.3344/kjp.2011.24.3.164. Epub 2011 Sep 6.

Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study

Muller F, Cugy E, Ducerf C, Delleci C, Guehl D, Joseph PA, Burbaud P, Dehail P.

Clin Rehabil. 2012 Feb;26(2):174-9. doi: 10.1177/0269215511412799. Epub 2011 Sep 21.

The effect of operant-conditioning balance training on the down-regulation of spinal H-reflexes in a spastic patient

Hoseini N, Koceja DM, Riley ZA.

Neurosci Lett. 2011 Oct 24;504(2):112-114. doi: 10.1016/j.neulet.2011.09.009. Epub 2011 Sep 16.

[The profile of adult patients with upper limb muscle spasticity treated with botulinum toxin type A (an international survey)]

Khat'kova SE, Timerbaeva SL, Orlova OR, Pozniakova EV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(8 Pt 1):23-6.

Assessing the neurophysiological effects of botulinum toxin treatment for adults with focal limb spasticity: a systematic review

Phadke CP, Ismail F, Boulias C.

Disabil Rehabil. 2012;34(2):91-100. doi: 10.3109/09638288.2011.591882. Epub 2011 Sep 27.

Early use of Xeomin neurotoxin for local anti-spasticity therapy for pes equines after acquired brain injury (ABI)

Lippert-Gruner M, Svestkova O.

Brain Inj. 2011;25(12):1266-9. doi: 10.3109/02699052.2011.613085. Epub 2011 Sep 30.

Alteration of protein folding and degradation in motor neuron diseases: Implications and protective functions of small heat shock proteins

Carra S, Crippa V, Rusmini P, Boncoraglio A, Minoia M, Giorgetti E, Kampinga HH, Poletti A.

Prog Neurobiol. 2012 May;97(2):83-100. doi: 10.1016/j.pneurobio.2011.09.009. Epub 2011 Sep 29.

Spondyloenchondrodysplasia: a rare cause of short stature

Yeşiltepe-Mutlu G, Ozsu E, Cizmecioğlu FM, Alanay Y, Hatun S.

Turk J Pediatr. 2011 Jul-Aug;53(4):464-6.

Bilateral subdural hematoma following implantation of intrathecal drug delivery device

Magro E, Remy-Neris O, Seizeur R, Allano V, Quinio B, Dam-Hieu P.

Neuromodulation. 2011 Mar-Apr;14(2):179-81; discussion 182. doi: 10.1111/j.1525-1403.2011.00335.x. Epub 2011 Mar 1.

The efficacy of electrical stimulation in reducing the post-stroke spasticity: a randomized controlled study

Sahin N, Ugurlu H, Albayrak I.

Disabil Rehabil. 2012;34(2):151-6. doi: 10.3109/09638288.2011.593679. Epub 2011 Oct 15.

Management of acute overdose or withdrawal state in intrathecal baclofen therapy

Watve SV, Sivan M, Raza WA, Jamil FF.

Spinal Cord. 2012 Feb;50(2):107-11. doi: 10.1038/sc.2011.112. Epub 2011 Oct 18.

Generalised tetanus in a 2-week-old foal: use of physiotherapy to aid recovery

Mykkänen AK, Hyytiäinen HK, McGowan CM.

Aust Vet J. 2011 Nov;89(11):447-51. doi: 10.1111/j.1751-0813.2011.00845.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias